NCT06643949

Brief Summary

Takotsubo syndrome (TTS) has recently been described as an acquired form of cardiomyopathy whose pathophysiology is not yet well understood and mainly affects postmenopausal women. TTS or "broken heart" syndrome was first described in Japan in 1991. The Japanese term "tako-tsubo" means "polyp vessel" and describes the morphology of the left ventricular apex during systole in patients with this condition. The onset usually follows physical or emotional stress and mimics that of acute coronary syndrome (ACS) with a parade of symptoms, including chest pain, dyspnea, syncope, and nausea. Objective examination is often normal or otherwise nonspecific. ECG may document ST-T changes while echocardiogram shows areas of altered ventricular kinetics. Serum cardiac biomarkers may be increased. Currently, the gold standard method for the diagnosis of TTS is coronarography, which documents epicardial coronary arteries that are normal or free of critical lesions. It is estimated that more than 2.5% of patients with a suspected diagnosis of ACS have TTS, and this number is probably underestimated. Although the prognosis of TTS is generally considered favorable, during the acute phase these patients can develop potentially fatal complications such as ventricular arrhythmias, cardiogenic shock, and heart rupture. Moreover, emerging scientific evidence sheds light on the need to adopt a dedicated diagnostic-therapeutic pathway for this type of patients. The exact pathophysiology of TTS is still unknown and no large population studies or registries are currently available. Therefore, the purpose of the study is to better characterize the profile of this disease through the creation of a large registry.

Trial Health

83
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,500

participants targeted

Target at P75+ for all trials

Timeline
142mo left

Started Jan 2008

Longer than P75 for all trials

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress61%
Jan 2008Dec 2037

Study Start

First participant enrolled

January 1, 2008

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2008

Completed
15.8 years until next milestone

First Submitted

Initial submission to the registry

October 14, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 16, 2024

Completed
13.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2037

Expected
Last Updated

October 16, 2024

Status Verified

October 1, 2024

Enrollment Period

1 year

First QC Date

October 14, 2024

Last Update Submit

October 14, 2024

Conditions

Keywords

takotsubocardiomyopathycardiogenic shockLVOTOmitral regurgitationheart failure

Outcome Measures

Primary Outcomes (1)

  • Major Adverse Cardiovascular Events (MACE)

    Composite of acute heart failure, takotsubo recurrence and mortality.

    1 year

Interventions

EchocardiographyDIAGNOSTIC_TEST

The registry will focus on the diagnostic and prognostic value of of echocardiographic features of patients with takotsubo syndrome

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients diagnosed with takotsubo syndrome.

You may qualify if:

  • Patients diagnosed with TTS in accordance with the InterTAK Diagnostic Criteria.

You may not qualify if:

  • Age less than 18 years
  • Myocarditis
  • Acute coronary syndrome
  • Myocardial infarction with non obstructive coronary arteries (MINOCA)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Takotsubo CardiomyopathyCardiomyopathiesShock, CardiogenicMitral Valve InsufficiencyHeart Failure

Interventions

Echocardiography

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesVentricular Dysfunction, LeftVentricular DysfunctionMyocardial InfarctionMyocardial IschemiaVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosisShockHeart Valve Diseases

Intervention Hierarchy (Ancestors)

Cardiac Imaging TechniquesDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisUltrasonographyHeart Function TestsDiagnostic Techniques, Cardiovascular

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

October 14, 2024

First Posted

October 16, 2024

Study Start

January 1, 2008

Primary Completion

December 31, 2008

Study Completion (Estimated)

December 31, 2037

Last Updated

October 16, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share